{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:50:40Z","timestamp":1782118240135,"version":"3.54.5"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006412","name":"Kharazmi University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.expneurol.2026.115646","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:17:40Z","timestamp":1768349860000},"page":"115646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Imipramine improves motor impairments in a rat model of Parkinson's disease induced by 6-hydroxydopamine; the role of oxidative stress and neurotrophic factors"],"prefix":"10.1016","volume":"399","author":[{"given":"Mahdi","family":"Hajibabaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagher","family":"Jafarvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Beirami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Valian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2026.115646_bb0005","series-title":"\u201cUse of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson\u2019s disease.\u201d 159(2): 195\u2013202","author":"Allbutt","year":"2007"},{"key":"10.1016\/j.expneurol.2026.115646_bb0010","series-title":"\u201cGDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration.\u201d 138(2): 155\u2013175","author":"Allen","year":"2013"},{"key":"10.1016\/j.expneurol.2026.115646_bb0015","series-title":"Protective Role of Apigenin on Rotenone Induced Rat Model of Parkinson\u2019s Disease: Suppression of Neuroinflammation and Oxidative Stress Mediated Apoptosis","first-page":"67","volume":"269","author":"Anusha","year":"2017"},{"key":"10.1016\/j.expneurol.2026.115646_bb0020","series-title":"\u201cMaturation but not Survival of Dopaminergic Nigrostriatal Neurons is Affected in Developing and Aging BDNF-deficient Mice.\u201d 1039(1\u20132): 177\u2013188","author":"Baker","year":"2005"},{"key":"10.1016\/j.expneurol.2026.115646_bb0025","series-title":"\u201cBrain-derived Neurotrophic Factor is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta.\u201d 25(26): 6251\u20136259","author":"Baquet","year":"2005"},{"key":"10.1016\/j.expneurol.2026.115646_bb0030","series-title":"\u201cAlterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson\u2019s disease: an influence of chronic pramipexole in rats.\u201d 10(3): e0117698","author":"Berghauzen-Maciejewska","year":"2015"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115646_bb0035","first-page":"865","article-title":"Antidepressant treatments-induced modifications of glutamatergic transmission in rat frontal cortex","volume":"60","author":"Bobula","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.expneurol.2026.115646_bb0040","series-title":"\u201cThe Role of Oxidative Stress in Parkinson\u2019s Disease.\u201d 9(7): 597","author":"Chang","year":"2020"},{"key":"10.1016\/j.expneurol.2026.115646_bb0045","series-title":"\u201cAntidepressant Treatment of Veterans with Parkinson\u2019s Disease and Depression: Analysis of a National Sample.\u201d 20(3): 161\u2013165","author":"Chen","year":"2007"},{"key":"10.1016\/j.expneurol.2026.115646_bb0050","series-title":"\u201cAutoradiography of Antidepressant Binding Sites in the Human Brain: Localization using [3H] Imipramine and [3H] Paroxetine.\u201d 27(2): 473\u2013496","author":"Cortes","year":"1988"},{"key":"10.1016\/j.expneurol.2026.115646_bb0055","first-page":"10","article-title":"GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway","volume":"9","author":"d\u2019Anglemont de Tassigny","year":"2015","journal-title":"Implic. Parkinson\u2019s Dis."},{"key":"10.1016\/j.expneurol.2026.115646_bb0060","series-title":"\u201cLoss of Dopaminergic Nigrostriatal Neurons Accounts for the Motivational and Affective Deficits in Parkinson\u2019s Disease.\u201d 19(3): 358\u2013367","author":"Drui","year":"2014"},{"key":"10.1016\/j.expneurol.2026.115646_bb0065","series-title":"\u201cAntiapoptotic and Neurotrophic Effects of Antidepressants: A Review of Clinical and Experimental Studies.\u201d 79(5): 248\u2013257","author":"Drzyzga","year":"2009"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115646_bb0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0197-0186(02)00049-9","article-title":"Noradrenergic regulation of inflammatory gene expression in brain","volume":"41","author":"Feinstein","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2026.115646_bb0075","series-title":"\u201cNeurotrophic Factors in Parkinson\u2019s Disease: What Have We Learned from Pre-clinical and Clinical Studies?\u201d 25(31): 3682\u20133702","author":"Ferreira","year":"2018"},{"key":"10.1016\/j.expneurol.2026.115646_bb0080","series-title":"Neuronal Degeneration and Oxidative Stress in the SNc of 6-OHDA Intoxicated Rats; Improving Role of Silymarin Long-term Treatment","first-page":"2427","volume":"393","author":"Haddadi","year":"2020"},{"issue":"on line","key":"10.1016\/j.expneurol.2026.115646_bb0085","first-page":"1","article-title":"Tricyclic antidepressant imipramine protects retina ganglion against oxidative stress induced apoptosis through TrkB signaling pathway","volume":"10","author":"Han","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.expneurol.2026.115646_bb0090","series-title":"\u201cImipramine Treatment Improves Cognitive Outcome Associated with Enhanced Hippocampal Neurogenesis after Traumatic Brain Injury in Mice.\u201d 28(6): 995\u20131007","author":"Han","year":"2011"},{"key":"10.1016\/j.expneurol.2026.115646_bb0095","series-title":"\u201cEffect of Imipramine on Memory, Adult Neurogenesis, Neuroinflammation, and Mitochondrial Biogenesis in a Rat Model of Alzheimer\u2019s Disease.\u201d 194: 112517","author":"Hasanabadi","year":"2024"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115646_bb0100","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nn1265","article-title":"Dopamine depletion impairs precursor cell proliferation in Parkinson disease","volume":"7","author":"H\u00f6glinger","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115646_bb0105","series-title":"\u201cReduced BDNF mRNA Expression in the Parkinson\u2019s Disease Substantia Nigra.\u201d 166(1): 127\u2013135","author":"Howells","year":"2000"},{"key":"10.1016\/j.expneurol.2026.115646_bb0110","series-title":"\u201cIntranasal Insulin Improves Mitochondrial Function and Attenuates Motor Deficits in a Rat 6-OHDA Model of Parkinson\u2019s Disease.\u201d 27(3): 308\u2013319","author":"Iravanpour","year":"2021"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115646_bb0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2377-11-88","article-title":"Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease","volume":"11","author":"Isaias","year":"2011","journal-title":"BMC Neurol."},{"key":"10.1016\/j.expneurol.2026.115646_bb0120","series-title":"Imipramine and Amitriptyline Ameliorate the Rotenone Model of Parkinson\u2019s Disease in Rats","first-page":"26","volume":"332","author":"Kandil","year":"2016"},{"key":"10.1016\/j.expneurol.2026.115646_bb0125","series-title":"\u201cResveratrol Attenuates 6-Hydroxydopamine-induced Oxidative Damage and Dopamine Depletion in Rat Model of Parkinson\u2019s Disease.\u201d 1328: 139\u2013151","author":"Khan","year":"2010"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115646_bb0130","first-page":"120","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson\u2019s disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.115646_bb0135","series-title":"The Open Field Test for Measuring Locomotor Activity and Anxiety-like Behavior","first-page":"99","author":"Kraeuter","year":"2019"},{"key":"10.1016\/j.expneurol.2026.115646_bb0140","series-title":"\u201cTremor and Rigidity in Patients with Parkinson\u2019s Disease: Emphasis on Epidemiology, Pathophysiology and Contributing Factors.\u201d 21(7): 596\u2013609","author":"Kumar","year":"2022"},{"key":"10.1016\/j.expneurol.2026.115646_bb0145","series-title":"\u201cEvidence for Oxidative Pathways in the Pathogenesis of PD: are Antioxidants Candidate Drugs to Ameliorate Disease Progression?\u201d 23(13): 6923","author":"Leathem","year":"2022"},{"key":"10.1016\/j.expneurol.2026.115646_bb0150","series-title":"\u201cAcid Sphingomyelinase Inhibitor, Imipramine, Reduces Hippocampal Neuronal Death after Traumatic Brain Injury.\u201d 23(23): 14749","author":"Lee","year":"2022"},{"key":"10.1016\/j.expneurol.2026.115646_bb0155","series-title":"\u201cImipramine Ameliorates Depressive Symptoms by Blocking Differential Alteration of Dendritic Spine Structure in Amygdala and Prefrontal Cortex of Chronic Stress-induced Mice.\u201d 28(3): 230","author":"Leem","year":"2020"},{"key":"10.1016\/j.expneurol.2026.115646_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2012.03.046","article-title":"MPTP-induced hippocampal effects on serotonin, dopamine, neurotrophins, adult neurogenesis and depression-like behavior are partially influenced by fluoxetine in adult mice","volume":"1457","author":"Lesemann","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2026.115646_bb0165","series-title":"\u201cAntidepressants Attenuate the Dexamethasone-induced Decrease in Viability and Proliferation of Human Neuroblastoma SH-SY5Y Cells: A Involvement of Extracellular Regulated Kinase (ERK1\/2).\u201d 63(5): 354\u2013362","author":"Leskiewicz","year":"2013"},{"key":"10.1016\/j.expneurol.2026.115646_bb0170","series-title":"Neurotrophic Factors and Neuroplasticity Pathways in the Pathophysiology and Treatment of Depression","first-page":"2195","volume":"235","author":"Levy","year":"2018"},{"key":"10.1016\/j.expneurol.2026.115646_bb0175","series-title":"Neuroprotective Effects of Mirtazapine and Imipramine and their Effect in Pro-and Anti-apoptotic Gene Expression in Human Neuroblastoma Cells","first-page":"563","volume":"72","author":"Lieberknecht","year":"2020"},{"key":"10.1016\/j.expneurol.2026.115646_bb0180","series-title":"\u201cRotenone Potentiates Dopamine Neuron Loss in Animals Exposed to Lipopolysaccharide Prenatally.\u201d 190(2): 373\u2013383","author":"Ling","year":"2004"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115646_bb0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.npp.1301571","article-title":"Interaction between BDNF and serotonin: role in mood disorders","volume":"33","author":"Martinowich","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2026.115646_bb0190","series-title":"\u201cBehavioral models of Parkinson\u2019s disease in rodents: a new look at an old problem.\u201d 21(10)","first-page":"1595","author":"Meredith","year":"2006"},{"key":"10.1016\/j.expneurol.2026.115646_bb0195","series-title":"BBPT Attenuated 6-OHDA-induced Toxicity by Modulating Oxidative Stress, Apoptotic, and Inflammatory Proteins in Primary Neurons and Rat Models of Parkinson\u2019s Disease","first-page":"67","volume":"105","author":"Mishra","year":"2024"},{"key":"10.1016\/j.expneurol.2026.115646_bb0200","series-title":"Ozone Modulates the Effects of Imipramine on Immobility in the Forced Swim Test, and Nonspecific Parameters of Hippocampal Oxidative Stress in the Rat","first-page":"125","volume":"25","author":"Mokoena","year":"2010"},{"key":"10.1016\/j.expneurol.2026.115646_bb0205","series-title":"The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson\u2019s Disease: Focus on Astrocytes","first-page":"28","volume":"49","author":"Niranjan","year":"2014"},{"key":"10.1016\/j.expneurol.2026.115646_bb0210","series-title":"\u201cImipramine Protects Mouse Hippocampus Against Tunicamycin-induced Cell Death.\u201d 696(1\u20133)","first-page":"83","author":"Ono","year":"2012"},{"key":"10.1016\/j.expneurol.2026.115646_bb0215","series-title":"The Role of Trophic Factors and Inflammatory Processes in Physical Activity-induced Neuroprotection in Parkinson\u2019s Disease","first-page":"713","volume":"71","author":"Pa\u0142asz","year":"2017"},{"key":"10.1016\/j.expneurol.2026.115646_bb0220","series-title":"Intranasal Insulin Protects against Substantia Nigra Dopaminergic Neuronal Loss and Alleviates Motor Deficits induced by 6-OHDA in Rats","first-page":"157","volume":"318","author":"Pang","year":"2016"},{"key":"10.1016\/j.expneurol.2026.115646_bb0225","series-title":"\u201cTricyclic Antidepressants Delay the Need for Dopaminergic therapy in Early Parkinson\u2019s Disease.\u201d 27(7)","first-page":"880","author":"Paumier","year":"2012"},{"key":"10.1016\/j.expneurol.2026.115646_bb0230","series-title":"\u201cChronic Amitriptyline Treatment Attenuates Nigrostriatal Degeneration and Significantly Alters Trophic support in a Rat Model of Parkinsonism.\u201d 40(4)","first-page":"874","author":"Paumier","year":"2015"},{"key":"10.1016\/j.expneurol.2026.115646_bb0235","series-title":"\u201cBregma, Lambda and the Interaural Midpoint in Stereotaxic Surgery with Rats of Different Sex, Strain and Weight.\u201d 13(2)","first-page":"139","author":"Paxinos","year":"1985"},{"key":"10.1016\/j.expneurol.2026.115646_bb0240","series-title":"\u201cNeuroprotection by Imipramine against Lipopolysaccharide-induced Apoptosis in Hippocampus-derived Neural Stem Cells Mediated by Activation of BDNF and the MAPK Pathway.\u201d 18(2)","first-page":"128","author":"Peng","year":"2008"},{"key":"10.1016\/j.expneurol.2026.115646_bb0245","series-title":"\u201cMitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration.\u201d 9(8)","first-page":"647","author":"Picca","year":"2020"},{"key":"10.1016\/j.expneurol.2026.115646_bb0250","series-title":"\u201cNew Insights on Brain-derived Neurotrophic Factor Epigenetics: from Depression to Memory Extinction.\u201d 1484(1)","first-page":"9","author":"Poon","year":"2021"},{"key":"10.1016\/j.expneurol.2026.115646_bb0255","series-title":"\u201cInhibiting BDNF Expression by Antisense Oligonucleotide Infusion Causes Loss of Nigral Dopaminergic Neurons.\u201d 192(1)","first-page":"226","author":"Porritt","year":"2005"},{"key":"10.1016\/j.expneurol.2026.115646_bb0260","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbi.2016.05.008","article-title":"Antidepressant imipramine diminishes stress-induced inflammation in the periphery and central nervous system and related anxiety-and depressive-like behaviors","volume":"57","author":"Ramirez","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2026.115646_bb0265","series-title":"\u201cHarmine and Imipramine Promote Antioxidant Activities in Prefrontal Cortex and Hippocampus.\u201d 3(5)","first-page":"325","author":"Reus","year":"2010"},{"key":"10.1016\/j.expneurol.2026.115646_bb0270","series-title":"\u201cAntidepressant Treatment Restores Brain-derived Neurotrophic Factor Serum Levels and Ameliorates Motor Function in Parkinson Disease Patients.\u201d 30(6)","first-page":"751","author":"Ricci","year":"2010"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115646_bb0275","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1523\/JNEUROSCI.23-01-00349.2003","article-title":"Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects","volume":"23","author":"Saarelainen","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115646_bb0280","series-title":"Post treatment with Gastrodin Suppresses Oxidative Stress and Attenuates Motor Disorders following 6-OHDA Induced Parkinson Disease","first-page":"136884","volume":"790","author":"Sadeghian","year":"2022"},{"key":"10.1016\/j.expneurol.2026.115646_bb0285","series-title":"\u201cNeurotrophic Factors in Alzheimer\u2019s and Parkinson\u2019s Diseases: Implications for Pathogenesis and Therapy.\u201d 12(4)","first-page":"549","author":"Sampaio","year":"2017"},{"key":"10.1016\/j.expneurol.2026.115646_bb0290","series-title":"Oxidative Damage to Macromolecules in Human Parkinson Disease and the Rotenone Model","first-page":"111","volume":"62","author":"Sanders","year":"2013"},{"key":"10.1016\/j.expneurol.2026.115646_bb0295","series-title":"\u201cDepressive-like Behaviors Alterations Induced by Intranigral MPTP, 6-OHDA, LPS and Rotenone Models of Parkinson\u2019s Disease are Predominantly Associated with Serotonin and Dopamine.\u201d 34(6)","first-page":"1104","author":"Santiago","year":"2010"},{"key":"10.1016\/j.expneurol.2026.115646_bb0300","series-title":"The Nonsteroidal Antiinflammatory Drug Piroxicam Reverses the Onset of Depressive-like Behavior in 6-OHDA Animal Model of Parkinson\u2019s Disease","first-page":"246","volume":"300","author":"Santiago","year":"2015"},{"key":"10.1016\/j.expneurol.2026.115646_bb0305","series-title":"\u201cImipramine Enhances Cell Proliferation and Decreases Neurodegeneration in the Hippocampus after Transient Global Cerebral Ischemia in Rats.\u201d 470(1)","first-page":"43","author":"Schiavon","year":"2010"},{"key":"10.1016\/j.expneurol.2026.115646_bb0310","series-title":"Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson\u2019s Disease","first-page":"554","volume":"55","author":"Shadfar","year":"2018"},{"key":"10.1016\/j.expneurol.2026.115646_bb0315","series-title":"\u201cBeneficial Effect of Antidepressants against Rotenone Induced Parkinsonism like Symptoms in Rats.\u201d 23(2)","first-page":"123","author":"Sharma","year":"2016"},{"key":"10.1016\/j.expneurol.2026.115646_bb0320","series-title":"\u201cIntracellular Magnesium Level Determines Cell Viability in the MPP+ Model of Parkinson\u2019s Disease.\u201d 1853(12)","first-page":"3182","author":"Shindo","year":"2015"},{"key":"10.1016\/j.expneurol.2026.115646_bb0325","series-title":"IDO-1 Inhibition Protects Against Neuroinflammation, Oxidative Stress and Mitochondrial Dysfunction in 6-OHDA Induced Murine Model of Parkinson\u2019s Disease","first-page":"184","volume":"84","author":"Sodhi","year":"2021"},{"key":"10.1016\/j.expneurol.2026.115646_bb0330","series-title":"\u201cComparison of the Capability of GDNF, BDNF, or Both, to Protect Nigrostriatal Neurons in a Rat Model of Parkinson\u2019s Disease.\u201d 1052(2)","first-page":"119","author":"Sun","year":"2005"},{"key":"10.1016\/j.expneurol.2026.115646_bb0335","series-title":"\u201cCellular and Molecular Mechanisms of Antioxidants in Parkinson\u2019s Disease.\u201d 15(3)","first-page":"120","author":"Sutachan","year":"2012"},{"issue":"11","key":"10.1016\/j.expneurol.2026.115646_bb0340","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1523\/JNEUROSCI.20-11-04030.2000","article-title":"cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment","volume":"20","author":"Thome","year":"2000","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115646_bb0345","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuroscience.2008.03.007","article-title":"Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex","volume":"153","author":"Tokarski","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2026.115646_bb0350","series-title":"Behavior and Oxidative Stress Parameters in Rats Subjected to the Animal\u2019s Models Induced by Chronic Mild Stress and 6-hydroxydopamine","first-page":"113226","volume":"406","author":"Tuon","year":"2021"},{"key":"10.1016\/j.expneurol.2026.115646_bb0355","series-title":"\u201cInfluence of LPS-induced Neuroinflammation on Acetylcholinesterase Activity in Rat Brain.\u201d 205(1\u20132)","first-page":"51","author":"Tyagi","year":"2008"},{"key":"10.1016\/j.expneurol.2026.115646_bb0360","series-title":"Low BDNF is associated with Cognitive Impairments in Patients with Parkinson\u2019s Disease","first-page":"66","volume":"29","author":"Wang","year":"2016"},{"key":"10.1016\/j.expneurol.2026.115646_bb0365","series-title":"Association of Low Serum BDNF with Depression in Patients with Parkinson\u2019s Disease","first-page":"73","volume":"41","author":"Wang","year":"2017"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115646_bb0370","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbagen.2015.11.008","article-title":"Imipramine administration induces changes in the phosphorylation of FAK and PYK2 and modulates signaling pathways related to their activity","volume":"1860","author":"Zalewska","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-General Subjects"},{"key":"10.1016\/j.expneurol.2026.115646_bb0375","series-title":"Brain Tissue Preparation, Sectioning, and Staining","first-page":"3","author":"Zhang","year":"2014"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:24:22Z","timestamp":1782116662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":75,"alternative-id":["S0014488626000099"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115646","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imipramine improves motor impairments in a rat model of Parkinson's disease induced by 6-hydroxydopamine; the role of oxidative stress and neurotrophic factors","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115646"}}